“…According to the literature published so far CA and its derivatives seem to be the most promising candidates for neuroprotective agents since they possess relatively higher antioxidant activity and are protective against a wider range of harmful factors when compared to other HCAs [ 8 , 10 , 12 , 13 ]. The representatives of this class of phenolic compounds most often studied so far in pre-clinical models of neurodegeneration include caffeic acid phenyl ester (CAPE, the main active component of propolis), chlorogenic acid (CGA, present in abundance in green coffee), chicoric acid, CA and rosmarinic acid (active component of rosemary herb) [ 14 , 15 , 16 , 17 , 18 , 19 ]. These compounds are characterized by pleiotropic mechanisms of action encompassing the activation of Nrf2/ARE/HO-1 pathway and induction of phase II enzymes (SOD, GSH, NADPH oxidase, xanthine oxidase), inhibition of calpains, attenuation of apoptotic and neuroinflammatory processes, inhibition of p38 and JNK pathways, induction of autophagy, activation of pro-survival PI3-K/Akt and MAPK/ERK1/2 pathways and stimulation of production of growth factors (NGF, BDNF, GDNF, VEGF) [ 5 , 6 , 7 , 15 , 18 , 20 , 21 , 22 , 23 , 24 , 25 ].…”